Rilvegostomig for Metastatic Non–Small Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study

Kristoffer S. Rohrberg, Mariana Brandão, Eduardo Castañón Álvarez, Enriqueta Felip, Eelke Gort, T. Jeroen N. Hiltermann, Hiroki Izumi, Dong-Wan Kim, Sang-We Kim, Luis Paz-Ares, Benjamin Solomon, Egbert F. Smit, Els Wauters, Tatsuya Yoshida, Amal Ayyoub, Huifang (Ariel) Chen, Steve Colebrook, Negar (Nikki) Hamidi, Michael Kuziora, KyoungSoo Lim, Ikbel Achour, Moritz W. Drachsler, Djuro Karanovic, Nelson Liu, Byoung Chul Cho

Open source

DOI: 10.1158/1078-0432.ccr-26-0333
Published: 2026-09-10
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-26-0333,
  title = {Rilvegostomig for Metastatic Non–Small Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study},
  author = {Kristoffer S. Rohrberg and Mariana Brandão and Eduardo Castañón Álvarez and Enriqueta Felip and Eelke Gort and T. Jeroen N. Hiltermann and Hiroki Izumi and Dong-Wan Kim and Sang-We Kim and Luis Paz-Ares and Benjamin Solomon and Egbert F. Smit and Els Wauters and Tatsuya Yoshida and Amal Ayyoub and Huifang (Ariel) Chen and Steve Colebrook and Negar (Nikki) Hamidi and Michael Kuziora and KyoungSoo Lim and Ikbel Achour and Moritz W. Drachsler and Djuro Karanovic and Nelson Liu and Byoung Chul Cho},
  year = {2026},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-26-0333},
  url = {https://doi.org/10.1158/1078-0432.ccr-26-0333}
}

RIS

TY  - JOUR
TI  - Rilvegostomig for Metastatic Non–Small Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study
AU  - Kristoffer S. Rohrberg
AU  - Mariana Brandão
AU  - Eduardo Castañón Álvarez
AU  - Enriqueta Felip
AU  - Eelke Gort
AU  - T. Jeroen N. Hiltermann
AU  - Hiroki Izumi
AU  - Dong-Wan Kim
AU  - Sang-We Kim
AU  - Luis Paz-Ares
AU  - Benjamin Solomon
AU  - Egbert F. Smit
AU  - Els Wauters
AU  - Tatsuya Yoshida
AU  - Amal Ayyoub
AU  - Huifang (Ariel) Chen
AU  - Steve Colebrook
AU  - Negar (Nikki) Hamidi
AU  - Michael Kuziora
AU  - KyoungSoo Lim
AU  - Ikbel Achour
AU  - Moritz W. Drachsler
AU  - Djuro Karanovic
AU  - Nelson Liu
AU  - Byoung Chul Cho
PY  - 2026
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-26-0333
UR  - https://doi.org/10.1158/1078-0432.ccr-26-0333
ER  -

APA

Rohrberg, K. S., Brandão, M., Álvarez, E. C., Felip, E., Gort, E., Hiltermann, T. J. N., Izumi, H., Kim, D., Kim, S., Paz-Ares, L., Solomon, B., Smit, E. F., Wauters, E., Yoshida, T., Ayyoub, A., Chen, H. (., Colebrook, S., Hamidi, N. (., Kuziora, M., Lim, K., Achour, I., Drachsler, M. W., Karanovic, D., Liu, N., & Cho, B. C. (2026). Rilvegostomig for Metastatic Non–Small Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-26-0333

Source records

crossref · retrieved 2026-09-27T03:19:59.994Z